PET/MRI与增强CT对胃癌术前分期诊断价值的比较

Comparison of diagnostic value of PET/MRI versus contrast-enhanced MDCT in preoperative staging of gastric cancer

  • 摘要: 目的 比较PET/MRI及增强CT在胃癌术前分期中的诊断效能。方法 收集2017年1月-2019年1月在我中心行PET/MRI检查的26例胃癌患者的资料。按照1∶2配比原则,选取同期在我中心行增强CT的52例胃癌患者作为对照组。分别对PET/MRI影像和增强CT影像进行判读,获得术前分期,与病理金标准对比进行诊断试验。结果 T1、T2、T3 ~ T4期灵敏度,PET/MRI为100%、50%和94%,而增强CT为70%、12%和91%。PET/MRI各分期的符合率分别为100%、88%和88%,高于增强CT的81%、62%和81%。在诊断N0期和胃大弯侧阳性淋巴结方面,PET/MRI诊断N0期和第7 ~ 12组阳性淋巴结的特异度为93%和88%,而增强CT为65%和47%。两者差异有统计学意义(P均<0.05)。其他各项指标,PET/MRI均优于增强CT。结论 PET/MRI检查在胃癌术前分期诊断中优于增强CT。

     

    Abstract: Objective To compare the diagnostic efficacy of PET/MRI versus contrast-enhanced MDCT in preoperative staging of gastric cancer. Methods From January 2017 to January 2019,PET/MRI was performed to 26 patients with gastric cancer in our center.Another 52 gastic cancer patients underwent contrast-enhanced MDCT were propensity-matched in a 1∶2 ratio.The PET/MRI and contrast-enhanced MDCT images were interpreted respectively for the preoperative staging.Then the diagnostic value of these two methods were compared according to the pathological gold standard. Results The sensitivity for T1,T2,T3-4 stage in PET/MRI was 100%,50% and 94%,which was higher than 70%,12% and 91% in contrast-enhanced MDCT.For accuracy,it was 100%,88% and 88% for T1,T2,T3-4 stage in PET/MRI,which was also higher than that in contrast-enhanced MDCT (81%,62% and 81%).PET/MRI was superior to contrast-enhanced MDCT in the specificity for diagnosis of both N0 and greater curvature positive lymph nodes,with 93% and 88% in PET/MRI,versus 65% and 47% in MDCT (P<0.05). Conclusion PET/MRI is superior to contrast-enhanced MDCT in diagnosis of preoperative staging of gastric cancer.

     

/

返回文章
返回